Summary of the 10 interactome components that display altered phenotypes in response to Xanthomonas oryzae oryzae Xoo
[[{'data': 'Name', 'colspan': 1, 'rowspan': 1}, {'data': 'Locus IDPutative Function#*', 'colspan': 1, 'rowspan': 1}, {'data': 'Genotype', 'colspan': 1, 'rowspan': 1}, {'data': 'Phenotype', 'colspan': 1, 'rowspan': 1}, {'data': 'Regulatory class', 'colspan': 1, 'rowspan': 1}]]
[['RAR1', 'LOC_Os02g33180CHORD family disease-resistance protein', '5 segregating F#3', 'Enhanced susceptibility to#Xoo', '(+) disease resistance, XA21-dependent'], ['OsEREBP-1', 'LOC_Os02g54160AP2 transcription factor', 'Overexpression of OsEREBP-1 in Kitakke', 'Enhanced resistance to#Xoo', '(+) disease resistance'], ['WAK25', 'LOC_Os03g12470Wall-associated receptor kinase', 'Overexpression and RNAi of WAK25 in Kit-XA21', 'OX: Enhanced resistance to#Xoo;#Xoo', '(+) disease resistance, XA21-dependent'], ['SCB3', 'LOC_Os03g14120Dihydrodipicolinate reductase', 'Overexpression of SCB3 in LiaoGeng', 'Enhanced resistance to#Xoo', '(+) disease resistance'], ['SnRK1A', 'LOC_Os05g45420Sucrose non-fermenting-1-related protein kinase-1', 'RNAi of SnRK1A in Kit-XA21', 'Enhanced susceptibility to#Xoo', '(+) disease resistance, XA21 dependent'], ['OsMPK12', 'LOC_Os06g49430Mitogen-activated protein kinase', 'Knockout of OsMPK12 in Dongjin', 'Enhanced susceptibility to#Xoo', '(+) disease resistance'], ['OsMPK5', 'LOC_Os03g17700Mitogen-activated protein kinase', 'RNAi of OsMPK5 in Nipponbare', 'Enhanced resistance to#Xoo', '(−) disease resistance'], ['OsWRKY76', 'LOC_Os09g25060WRKY transcription factor', 'Overexpression of OsWRKY76 in Kit-XA21', 'Enhanced susceptibility to#Xoo', '(−) disease resistance, XA21-dependent'], ['SAB23', 'LOC_Os12g32980PHD domain protein', '3 segregating F#3', 'Enhanced susceptibility to#Xoo', '(−) disease resistance, XA21-dependent'], ['SAB18', 'LOC_Os11g06410SANT domain transcription factor', 'Knockout of SAB18 in Dongjin', 'Enhanced tolerance to submergence', '(−) submergence tolerance']]================================================================================